CEFACLOR (cefaclor) by Inpharmus is clinical pharmacology cefaclor is well-absorbed after oral administration to fasting subjects. Approved for the treatment of the following infections, haemophilus influenzae, staphylococci and 2 more indications. First approved in 2012.
Drug data last refreshed 20h ago
CLINICAL PHARMACOLOGY Cefaclor is well-absorbed after oral administration to fasting subjects. Total absorption is the same whether the drug is given with or without food; however, when it is taken with food, the peak concentration achieved is 50% to 75% of that observed when the drug is…
Worked on CEFACLOR at Inpharmus? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria